StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Diosmin

HCID 5281613
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
520-27-4
Standard-SMILES
COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O
InChIKey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
Summenformel
C28H32O15
Durchschnittliche Molmasse
608,5 g/mol
Monoisotopische Masse
608,17412032

Überblick

Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a monomethoxyflavone, a rutinoside, a dihydroxyflavanone, a glycosyloxyflavone and a disaccharide derivative. It is functionally related to a diosmetin.

Namen und Bezeichner

Bevorzugter Name
Diosmin
IUPAC
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
Lokaler Name
Diosmin
Englischer Name
Diosmin
Summenformel
C28H32O15
Molmasse
608.55

Namen und Synonyme

diosmin520-27-4BarosminVenosmineDiosmineFlebostenToveneVen-DetrexDiovenorBuchu ResinLitosmilflebosmil
Weitere Namen anzeigen
DIOSMETIN-7-O-RUTINOSIDEHesperedinDIOSIMINSiF6Rubber powderDaflonDiosmin CRSDioveniosmin
DiosminumFlebavenaDiosmetin 7-O-rutinosideDiosvenFlebavenHemervenInsuvenVarinon

Datenbank-Bezeichner

CAS
520-27-4
PubChem CID
5281613
DTXSID
DTXSID4045892
ChEMBL
CHEMBL231884
ChEBI
CHEBI:4631
UNII
7QM776WJ5N
EC Number
208-289-7
Nikkaji
J6.600A

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,8
Polarare Oberfläche (TPSA)
234 Ų
H-Brücken-Donoren
8
H-Brücken-Akzeptoren
15
Frei drehbare Bindungen
7
Schwere Atome
43
Formalladung
0
Komplexität
995

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Used in Switzerland

LipidsPolyketides [PK] -> Flavonoids [PK12] -> Flavones and Flavonols [PK1211]
CosmeticsAntioxidant
LogP0.14
Boiling Point926.8±65.0
Melting Point277-278
Dissociation Constants6.10±0.40
Collision Cross Section · 2 Einträge

243.33 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

242.5 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 3 Einträge

This chemical does not meet GHS hazard criteria for 90.8% (89 of 98) of all reports.

Not Classified

Aggregated GHS information provided per 98 reports by companies from 2 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory InformationStatus: Active Update: 13-11-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/21071
Hazard Classes and CategoriesNot Classified

Sicherheitsdaten

wgk
3
hs_code
29381000
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36-36/37-24/25
Speicherklasse
11 - Combustible Solids

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingDiosmin binds to serum albumin.
Pharmacodynamics · 1 Eintrag

Diosmin is a venoactive drug supporting circulatory health through various actions on blood vessels; it supports lymphatic drainage and improves microcirculation while increasing venous tone and elasticity. For these reasons, diosmin is frequently taken by individuals with chronic venous disease to support vascular health and has been demonstrated to improve quality of life. In addition to the above effects, diosmin exerts antioxidant activity and scavenges oxygen free radicals, reducing levels of oxidative stress normally detected through biomarkers such as prostaglandins isoprostane precursors. In one clinical study, mean content of TNF alpha, VEGF-C, VEGF-A IL-6, in addition to FGF2 were decreased by after the therapy with diosmin; findings were statistically significant. Additionally, a decrease in edema and mean leg circumference of patients taking diosmin for three months was observed in a clinical study. Diosmin has been demonstrated to enhance the metabolism of glucose in diabetic disorders.

Mechanism of Action · 1 Eintrag

Diosmin helps to maintain circulatory system structure and function, particularly vein strength and competence. The molecular mechanism of action of diosmin has not been established. Several resources indicate that diosmin binds to the aryl hydrocarbon receptor, however clinical relevance to vascular function is unknown. One study demonstrates that oral diosmin exerts effects on the in vitro metabolism of noradrenaline by varicose veins, potentially benefitting vascular health.

Biological Half-LifeDiosmin half-life ranges from 26 to 43 hours. One study using a liquid chromatography with tandem mass spectrometry (LC-MS/MS) method after a single 900 mg dose of diosmin demonstrated a half-life of 60.2±85.7 hours in healthy volunteers.
Metabolism/MetabolitesDegradation products of diosmin such as alkyl-phenolic acids confirm a metabolic pattern similar to that of other flavonoids.

Zugehörige Reaktionen

3
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 61526
HRID 61526als Edukt
Reaktionsgleichung von HRID 2222318
HRID 2222318als Edukt
Reaktionsgleichung von HRID 2230904
HRID 2230904als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Schmelzpunkt
277 · 277-278°C
Siedepunkt
926.8 · 926.8±65.0 °C(Predicted)
Dichte
1.68 · 1.68±0.1 g/cm3(Predicted)
Dampfdruck
0 Pa · 0Pa at 20℃
storage temp.
2 · Sealed in dry,2-8°C
Löslichkeit
Practically insoluble in water, soluble in dimethyl sulfoxide, practically insoluble in alcohol. It dissolves in dilute solutions of alkali hydroxides.
Aggregatzustand
Solid
pka
6.1 · 6.10±0.40(Predicted)
Farbe
Pale Beige to Brown
Wasserlöslichkeit
Soluble in DMSO (50 mg/ml), water (122 mg/ml at 25°C), and ethanol (<1 mg/ml at 25°C).
Merck
14 · 14,3297
Major Application
food and beverages
Kosmetik-Inhaltsstoffe Funktionen
ANTIOXIDANT
InChIKey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
SMILES
COc1ccc(cc1O)C2=CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2
LogP
0.14 at · 0.14 at 20℃
CAS Datenbank
520 · 520-27-4(CAS DataBase Reference)
Absorption, Distribution and Excretion · 3 Einträge

Diosmin is rapidly absorbed in the gastrointestinal tract. After a 900 mg single oral dose in a study using liquid chromatography with tandem mass spectrometry (LC-MS/MS) method, Cmax was 4.2±3.8 ng·mL-1, Tmax was 18.7±9.9 hours, and AUC0~96 was 185.4±166.2 ng·mL-1 in healthy volunteers. Another pharmacokinetic study of 5 adults revealed a Cmax of 417±94.1 ng/dL.

Pharmacokinetic data show absence of urinary elimination for diosmin and its aglycone diosmetin. Minor metabolites are found to be eliminated in the urine as glucuronic acid conjugates.

A pharmacokinetic study of 5 adults revealed a volume of distribution of 62.1±7.9 L.

Verwendung und Herstellung

UsesUse (kg) in France (2004): 373544
Use ClassificationCosmetics -> Antioxidant
Anwendungen · 3 Einträge

BeschreibungDiosmin was separated from the root of Scrophularia nodosa L. in 1925. The root of Scrophularia nodosa L. has the function of nourishing, reducing fever, relieving internal heat, and detoxicating. It was firstly recorded in the Shen Nong’s Classic of Materia Medica, as a class of middle-grade drug and is currently recorded in the Ch.P 2015, Volume I. The natural resource was abundant in China, mainly provided from Zhejiang, Sichuan, Hubei, Anhui, and Jiangsu provinces. In the clinical practice, Scrophularia nodosa L. was employed to eliminate pathogenic heat from the blood. In the clinical indication, diosmin was mainly applied to treat fever, polydipsia, maculitis, gingivitis, amygdalitis, laryngopharyngitis, acute lymphadenitis, etc. It also has the biological function of antiplatelet aggregation and antitumor. The chemical components include iridoids, phenylpropanoid glycoside, flavonoids, and fatty acids.

HistoryDiosmin was firstly introduced as a medicine in 1969. It was launched in France in 1987 with the product name “Alvenor.” As the protecting agent for blood vessel and therapeutic agent for chronic venous disease, diosmin has been used for over 30years in EuropeDiosmin is a typical flavonoid. It could be prepared from natural resources or semisynthesized from the natural product hesperidin by dehydrogenation reaction.

VerwendenDiosmin is an agonist of the aryl hydrocarbon receptor (AhR) and exhibits anti-proliferative and anti-inflammatory. It is used in the treatment of venous disease, i.e., chronic venous insufficiency (CVI) and hemorrhoidal disease (HD). Diosmin also reduces capillary hyperpermeability and expression of endothelial adhesion molecules (ICAM1, VCAM1). It effectively inhibits the P-glycoprotein (Pgp)-mediated efflux in cells.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

NatriumhydroxidEssigsureHesperidinEssigsäureanhydrid
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a glycosyloxyflavone, a rutinoside, a disaccharide derivative, a monomethoxyflavone and a dihydroxyflavanone. It derives from a diosmetin.